IRIS UniCatt

De Candia, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.561
EU - Europa 2.236
AS - Asia 2.085
SA - Sud America 477
AF - Africa 62
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.491
SG - Singapore 1.031
CN - Cina 503
DE - Germania 427
BR - Brasile 410
PL - Polonia 380
SE - Svezia 379
IT - Italia 338
UA - Ucraina 139
IE - Irlanda 134
VN - Vietnam 110
GB - Regno Unito 106
FR - Francia 102
IN - India 91
ID - Indonesia 79
FI - Finlandia 66
RU - Federazione Russa 51
HK - Hong Kong 38
MX - Messico 31
CA - Canada 30
AR - Argentina 28
TR - Turchia 28
IQ - Iraq 27
JP - Giappone 26
BD - Bangladesh 25
AT - Austria 22
IR - Iran 20
BE - Belgio 19
NL - Olanda 19
KR - Corea 17
ZA - Sudafrica 17
AU - Australia 15
EC - Ecuador 14
EG - Egitto 13
PK - Pakistan 13
ES - Italia 11
HU - Ungheria 11
JO - Giordania 11
MA - Marocco 11
UZ - Uzbekistan 11
IL - Israele 8
MY - Malesia 7
VE - Venezuela 7
CH - Svizzera 6
KE - Kenya 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
PY - Paraguay 5
SA - Arabia Saudita 5
BH - Bahrain 4
CI - Costa d'Avorio 4
CL - Cile 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MK - Macedonia 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
NP - Nepal 3
PH - Filippine 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
LB - Libano 2
MN - Mongolia 2
PE - Perù 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.441
Salva come PNG Salva come JPEG
Città #
Singapore 525
Warsaw 373
Chandler 333
Ashburn 298
Dublin 128
Beijing 110
Fairfield 106
San Mateo 90
Wilmington 85
Los Angeles 76
Jakarta 71
Rome 71
Jacksonville 67
New York 62
Woodbridge 62
Hefei 60
Ann Arbor 59
Nanjing 59
Munich 56
Seattle 50
Boston 48
Houston 48
Marseille 42
Ho Chi Minh City 40
Hong Kong 36
Moscow 36
Princeton 36
Milan 35
Boardman 34
Chicago 33
Dearborn 33
São Paulo 32
Cambridge 28
Cattolica 28
Redwood City 28
Buffalo 27
Dallas 27
Hanoi 27
Hyderabad 22
Lawrence 20
London 20
Frankfurt am Main 19
The Dalles 19
Nanchang 18
Nuremberg 18
Helsinki 17
Rio de Janeiro 17
Brussels 16
Seoul 16
Tokyo 14
Augusta 13
Hangzhou 13
Redmond 13
Turku 13
Andover 12
Kent 12
Nürnberg 12
Pune 12
Council Bluffs 11
Curitiba 11
Izmir 11
Norwalk 11
Bremen 10
Budapest 10
Denver 10
Mountain View 10
San Diego 10
Tashkent 10
Vienna 10
Zhengzhou 10
Amman 9
Guangzhou 9
Guarulhos 9
Johannesburg 9
Montreal 9
Verona 9
Washington 9
Baghdad 8
Bari 8
Belo Horizonte 8
Brasília 8
Hebei 8
Lappeenranta 8
Salvador 8
San Francisco 8
San Jose 8
Atlanta 7
Brooklyn 7
Chennai 7
Düsseldorf 7
Guayaquil 7
Kunming 7
North Bergen 7
Phoenix 7
Shenyang 7
University Park 7
Campo Grande 6
Changsha 6
Cuauhtémoc 6
Erbil 6
Totale 4.028
Salva come PNG Salva come JPEG
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 324
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 260
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 191
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 182
Data on the application of early coagulation support protocol in the management of major trauma patients 166
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 157
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 155
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 154
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 153
Effect of fibrinogen concentration on the velocity of platelet aggregation. 136
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 131
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 130
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 127
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 127
Functional role of protease activated receptors in vascular biology 126
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 124
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 119
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 119
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 118
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 117
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 110
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 109
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 109
Hemophilia A and von Willebrand deficiency: therapeutic implications 108
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 108
Mechanisms of platelet activation by thrombin: a short history 107
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 107
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 107
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 106
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 104
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 103
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 99
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 99
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 99
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 96
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 96
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 96
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 93
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 91
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 90
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 90
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 88
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 86
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 86
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 85
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 84
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 82
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 81
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 80
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 80
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 79
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 77
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 77
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 76
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 73
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 72
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 72
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 71
Extended coagulation profile of children with Long Covid: a prospective study 69
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 69
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 69
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 68
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 68
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II 65
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 63
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 61
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 61
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 59
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 57
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 56
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 52
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets 40
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 29
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 25
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders 23
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 19
PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia 9
Totale 7.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 73 46 21 50 44 90 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/20251.235 24 32 113 64 65 46 42 49 172 133 302 193
2025/20262.082 527 155 225 391 638 146 0 0 0 0 0 0
Totale 7.554